|
|
|
l |
Home | l | UK Companies | l | Genomics Topics | l | Species with sequenced Genomes | l | Contact |
l |
|
Loading...
| ||||||||||||||
Recent Publications by Pfizer Animal Health: | ![]() | |
| Prevention of respiratory disease in cow/calf operations.
Respiratory disease in nursing calves is a common, yet sporadic herd... | Pfizer Animal Health, Cooperstown, | Vet Clin North Am Food Anim Pract. 2010 Jul;26(2):229-41.
DOI Direct Link |
| Effects of perzinfotel on the minimum alveolar concentration of isoflurane in dogs when administered as a preanesthetic via various routes or in combination with butorphanol.
OBJECTIVE: To determine the anesthetic-sparing effects of perzinfotel when... | Pfizer Animal Health Australia, PO Box 57, West Ryde, NSW 2114, Australia. | Am J Vet Res. 2010 Jun;71(6):604-9.
DOI Direct Link |
| Field efficacy and safety of an oral formulation of the novel combination anthelmintic, derquantel-abamectin, in sheep in New Zealand.
AIM: To evaluate the efficacy and safety of the novel anthelmintic... | Veterinary Medicine Research & Development, Pfizer Animal Health, 45 | N Z Vet J. 2010 Jun;58(3):121-9. |
| The relative contribution of efflux and target gene mutations to fluoroquinolone resistance in recent clinical isolates of Pseudomonas aeruginosa.
The clinical utility of fluoroquinolones (FQs) for the treatment of... | Pfizer Animal Health, Kalamazoo, MI 49007, USA. | Eur J Clin Microbiol Infect Dis. 2010 Mar;29(3):279-88. Epub 2010 Jan 23.
DOI Direct Link |
| Pharmacokinetic properties of toceranib phosphate (Palladia, SU11654), a novel tyrosine kinase inhibitor, in laboratory dogs and dogs with mast cell tumors.
Toceranib phosphate (Palladia, SU11654), an oral tyrosine-kinase... | Pfizer Animal Health, | J Vet Pharmacol Ther. 2010 Apr;33(2):162-71.
DOI Direct Link |